-+ 0.00%
-+ 0.00%
-+ 0.00%

Cube Pharmaceuticals (003020.SZ): Application for marketing of cloprocaine hydrochloride as an API approved

Zhitongcaijing·10/13/2026 09:33:13
Listen to the news

Zhitong Finance App News, Cube Pharmaceutical (003020.SZ) issued an announcement. Recently, the company received the “Notice of Approval of the Marketing Application for Chemical Ingredient” for cloprocaine hydrochloride issued by the State Drug Administration. Cloprocaine hydrochloride is a local anesthetic that blocks sodium ion channels in nerve endings, making nerve impulses unable to be transmitted, thereby blocking the conduction of sensory nerve endings and producing local anesthetic effects. Its formulation is suitable for local infiltration anesthesia, peripheral nerve block anesthesia, sacral canal and epidural anesthesia.